Improving life. It’s what drives us each day. At Fluidigm, we empower our customers to reveal meaningful insights in health and disease, identify actionable markers to inform treatment decisions and accelerate the development of more effective therapies.
We focus on the most pressing needs in translational and clinical research, including cancer, immunology and immunotherapy. Harnessing the power of proprietary CyTOF® and microfluidics technologies, we provide comprehensive multi-omics solutions through our unique combination of innovative mass cytometry, tissue imaging and genomics capabilities.
Researchers depend on our systems to uncover significant disease pathways, find valuable new molecular biomarkers and deeply profile relevant cell populations down to single-cell resolution. As a trusted partner of leading academic, government, pharmaceutical, biotechnology and plant and animal research laboratories worldwide, we strive to increase the quality of life for all.
The Advanta™ Dx SARS-CoV-2 RT-PCR Assay is for In Vitro Diagnostic Use. It is for Use under Emergency Use Authorization Only. Rx Only. Other Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.